Events Archive

If you'd like to connect, shoot us an email.

Shoot us an email and let’s catch up.

Catalyst Founder and CEO, Nancy Myers, moderated a panel on Thursday, September 24th, 2020 at the (virtual) ASGCT Policy Summit. The panel was on "Overcoming Regulatory Challenges in Gene Therapy Development." The [...]

Catalyst Healthcare Consulting will be speaking at an Informa Pharma Intelligence COVID-19 24-hour Webinar Series Event: Lessons Learned and a Path Forward on July 21-22, 2020. The COVID-19 pandemic has shifted how [...]

Catalyst Healthcare Consulting will be speaking at a number of events this spring and summer. Come join us as we explore some of the key issues and trends impacting the environment for [...]

Come and join us on Jan. 8 as Catalyst President Nancy Bradish Myers speaks as part of a panel on “The impact of new leadership and new initiatives at FDA.” The panel, [...]

Join us on Jan. 9 as Catalyst President Nancy Bradish Myers speaks as part of a panel entitled “Once the train has left the station, is it possible to regulate?” at the [...]

Catalyst VP-Regulatory Policy and ex-FDAer Jill Hartzler Warner, JD, will analyze the changing regulatory environment for biopharma and device companies as part of an FDANews expert panel series this Fall. Ms. Warner [...]

On June 13, Catalyst President Nancy Bradish Myers will present on PDUFA and other user fee agreements, and their impact on drug competition. Ms. Myers will be a featured speaker for the [...]

Catalyst will moderate two panel discussions exploring various types of disruptive innovation during the DIA’s 2017 Annual Meeting. On June 20, Catalyst President Nancy Bradish Myers will moderate a panel exploring “Regulatory [...]

During the RxAdherence “Strategies to Improve Outcomes” annual meeting, Catalyst President Nancy Bradish Myers will give a presentation on FDA the Trump Administration. Ms. Myers’ presentation at the 2017 annual meeting, held [...]

This year’s Food & Drug Law Institute Annual Conference will feature a panel on FDA under the Trump Administration. Catalyst President Nancy Bradish Myers will join the panel, which will be moderated [...]

What can we anticipate from FDA in the Trump Administration? How might new policies impact innovation and product development? Join us on Jan. 10 as Catalyst President Nancy Bradish Myers offers insights [...]

Catalyst President Nancy Bradish Myers and fellow Big Data panelists took time out from the DIA annual meeting to talk about how Big Data is transforming drug development and health [...]

Just how BIG will Big Data be? Come hear from top thought-leaders about the coming “data tsunami,” and the innovations in the pipeline that will both generate and harness Big Data to disrupt the [...]

On May 6, on behalf of the FDA Alumni Association (FDAAA), Catalyst President Nancy Bradish Myers will present former FDA Commissioner Mark McClellan with the 2016 Harvey W. Wiley Lecture Award. Ms. [...]

What are the important regulatory issues for investors and biopharma companies in 2016? Join us during the 8th annual Biotech Showcase conference on Jan. 13, as Catalyst offers insights on key regulatory [...]

How have FDA drug reviews been affected by initiatives such as Patient-Focused Drug Development and the push for better use of PROs? How is the agency incorporating the patient viewpoint, and what [...]

On Nov. 3, Catalyst will serve as discussion leader for a roundtable on PDUFA VI negotiations, as part of the annual Partnering for Cures conference in New York City. Catalyst President Nancy [...]

In a roundup of highlights from day three of its annual meeting, DIA includes two panels moderated by Catalyst. As part of the coverage, DIA has posted videos of select portions of [...]

Catalyst is moderating two separate panel discussions at the Drug Information Association (DIA) annual meeting. On June 17, join us for in-depth discussions on timely subjects: 21st Century Cures legislation, and Precision [...]

Catalyst President Nancy Bradish Myers will participate as a panelist at the 7th DIA China Annual Meeting, to be held in Shanghai, May 24-27, 2015. Ms. Myers will speak about US FDA/industry [...]

Catalyst President Nancy Bradish Myers will moderate a panel discussion on genomics and Precision Medicine at the Drug Information Association’s annual meeting on June 17, 2015, in Washington, DC. The panel, entitled [...]

Catalyst President Nancy Bradish Myers will moderate a panel at the Drug Information Association’s annual meeting, which will take place June 17, 2015 in Washington, DC; entitled “21st Century Cures: Which Are [...]

Catalyst President Nancy Bradish Myers will moderate two panel discussions during DIA’s 50th Annual Meeting, to be held June 15-19, 2014 in San Diego. Her sessions, both scheduled for June 17, will [...]

Catalyst President Nancy Bradish Myers will be in San Francisco for the JP Morgan annual conference again this year. She will be meeting with current and prospective clients during the conference, to [...]

Catalyst President Nancy Bradish Myers will participate as a panelist in this year’s Life Sciences Summit in New York City. The panel, which will explore “FDA: An Organization in Change and What [...]

Catalyst President Nancy Bradish Myers has joined the Program Committee for the Drug Information Association’s 50th Annual Meeting, to be held in June 2014. In addition, she will serve as Co-Chair of [...]

Catalyst President Nancy Bradish Myers will moderate a panel addressing FDA collaboration with other federal agencies, as part of the Food & Drug Law Institute’s Annual Conference. This “Interagency Dynamics” panel will [...]

Under the Breakthrough Therapy designation, enacted as part of FDASIA, FDA has been working to expedite development and review of drugs that show “substantial improvement” over existing therapies for serious and life-threatening [...]

Catalyst President Nancy Bradish Myers will serve as moderator for a panel on “The New Generic Drug Era” at The Pink Sheet and the RPM Report’s FDA/CMS Summit on Dec. 11. The [...]

User fee expert and Catalyst Healthcare Consulting President Nancy Bradish Myers will serve as session moderator for a panel on implementation of recently enacted user fee legislation. The panel will cover key [...]

Catalyst Healthcare Consulting President Nancy Bradish Myers, JD, will teach a session on "FDA and the Prescription Drug User Fee Act" as part of a week-long executive education program for biotech and [...]

Catalyst President Nancy Bradish Myers will participate in a panel discussion during the Food and Drug Law Institute's 55th annual conference in Washington, DC. The panel, set for April 25, will explore [...]

On Jan. 11, Catalyst Healthcare Consulting's Nancy Bradish Myers will speak at a workshop on innovation and regulatory strategy. Entitled "Getting a Drug Approved as FDA is Evolving," the workshop is part [...]

During the "FDA at a Crossroads" conference on Nov. 15, Catalyst President Nancy Bradish Myers will participate on a panel entitled "Institutional Challenges at the FDA." The panel will be moderated by [...]

CHI will kick off its annual meeting with a panel on innovation in oncology and access to therapy. Catalyst President Nancy Bradish Myers will participate on the panel and present her perspective [...]

During the Sept. 22 Town Hall meeting, featuring CDRH Director Jeff Shuren and senior Center management, Catalyst President Nancy Bradish Myers will present recommendations for CDRH on facilitating and promoting innovation. CDRH's [...]

Moderated by Catalyst President Nancy Bradish Myers, this panel will explore lessons learned from the prescription drug and medical device user fee program negotiations (PDUFA and MDUFA), and how those lessons may [...]

Ms. Myers will participate on a panel addressing trends in drug approvals. She will join moderator Michael S. Labson, Partner, Covington & Burling and fellow panelist Klara A. Dickinson, Senior Vice President, [...]

FasterCures, the Washington, DC-based center of the Milken Institute, is convening the second annual Partnering for Cures meeting on December 14-15, 2010 in New York City. Catalyst President Nancy Bradish Myers will [...]

Catalyst Healthcare Consulting President Nancy Bradish Myers, JD, will speak at Windhover's FDA/CMS Summit as part of a panel on drug safety, entitled "Equal Voice: The Drug Safety Side of FDA." The [...]

Catalyst Healthcare Consulting President Nancy Bradish Myers, JD, will teach "Trends at the FDA" as part of a week-long executive education program at the Wharton School in Philadelphia. She will co-present with [...]

Catalyst Healthcare Consulting, Inc. President Nancy Bradish Myers, JD, will lead a breakout session on personalized medicine at the Food and Drug Law Institute’s 53rd annual conference. The panel will address key [...]

Ms. Myers has been asked to kick off the Food and Drug Law Institute’s two-day in house training session entitled “Introduction to Drug Law and Regulation: Understanding How FDA Regulates the Drug [...]